Home › Membranous Glomerulonephritis › New York
Membranous Glomerulonephritis clinical trials in New York
3 studies for Membranous Glomerulonephritis are looking for participants at sites in New York.
Cities in New York
Belimumab With Rituximab for Primary Membranous Nephropathy
- Columbia University Medical Center: Division of Nephrology, New York
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT03949855NEPTUNE Match Study
- Northwell/Cohen's Children's Hospital, New Hyde Park
- Columbia University Medical Center, New York
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- Cohen Children's Hospital, New Hyde Park
- New York University Medical Center, New York
- Bellevue Hospital, New York
- and 3 more
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.